Cadence Pharmaceuticals, Inc. (CADX) Posts Q3 Loss of 34c/Share
Tweet
Share
E-mailGet Alerts CADX Hot Sheet
Price: $13.98 --0%
Financial Fact:
Total other expense, net: -1.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total other expense, net: -1.12M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) reported Q3 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
